Vera Therapeutics, Inc. · NASDAQ:VERA
Fordyce Marshall sold 22,951 Vera Therapeutics, Inc. shares (Form 4)
Traded Apr 14, 2026 · Filed Apr 15, 2026
On Apr 14, 2026, Fordyce Marshall (Director, PRESIDENT AND CEO) sold 22,951 Vera Therapeutics, Inc. shares at an average US$44.05 for US$1.01M under a trading plan, leaving 235,244 shares. Filed Apr 15, 2026 (Form 4).
- Sold
- 22,951 shares
- Price
- US$44.05 average (US$43.66 to US$45.51)
- Value
- US$1.01M
- Holding after
- 235,244 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, PRESIDENT AND CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 14, 2026 | Class A Common Stock | Sale | 14,130 | US$43.66 | 244,065 | Direct |
| Apr 14, 2026 | Class A Common Stock | Sale | 7,921 | US$44.58 | 236,144 | Direct |
| Apr 14, 2026 | Class A Common Stock | Sale | 900 | US$45.51 | 235,244 | Direct |
Source
Related
- Vera Therapeutics, Inc.
- Fordyce Marshall
- Vera Therapeutics, Inc. shareholders
- Form 4 · Fordyce Marshall · Sep 17, 2026
- Form 4 · Fordyce Marshall · Sep 4, 2026
- Form 4/A · Fordyce Marshall · Aug 12, 2026
- Form 4/A · Fordyce Marshall · Aug 12, 2026
- Form 4/A · Fordyce Marshall · Aug 12, 2026
- Form 4 · Young Joseph R · Sep 14, 2026
- Schedule 13G/A · Kynam Capital Management, LP · Aug 14, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Boman Nancy Lee · Aug 5, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 30, 2026